Meet Our Team We make a serious commitment to helping you get the results you want and the care you need
The GLORY-1 trial reported gastrointestinal symptoms as the most common adverse events, but discontinuation rates due to these effects remained low
Is compounded tirzepatide safer than Mounjaro
The provider's visit note and care plan are shared automatically with the members health coach and clinical specialists, who start tailoring their support
Ovarian stimulation and endometriosis progression or recurrence: a systematic review

A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), Diabetes Care (2018) Effect of semaglutide and liraglutide in individuals with obesity or overweight without diabetes: a systematic review, Therapeutic Advances in Chronic Disease (2022) Clinical insight on semaglutide for chronic weight management in adults: Patient selection and special considerations, Drug Design, Development and Therapy (2022) Wegovy, DailyMed (2024) Rybelsus, DailyMed (2024) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network (2022) One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center, Endocrine Practice (2020) Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes2022 , American Diabetes Association (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
